Ampersand Capital Partners and Accel-KKR Invests in Fitzgerald Industries | PrivSource

Ampersand Capital Partners and Accel-KKR Invests in Fitzgerald Industries

04.20.2023

Fitzgerald Industries manufactures and supplies antibodies, proteins, and research products for researchers and diagnostic companies. It is a supplier of primary and secondary antibodies, recombinant and native proteins, ELISA kits, serum, and plasma.

ACQUIRER/INVESTOR

Ampersand Capital Partners

Accel-KKR

SELLER

Trinity Biotech

PLATFORM

Biosynth

https://ampersandcapital.com/trinity-biotech-announces-the-30-million-sale-of-its-life-sciences-supply-business-to-biosynth/

The Premium Lower and Middle Market M&A Platform

For full transactional data, join PrivSource today!